2.70
price down icon0.74%   -0.02
after-market 시간 외 거래: 2.70
loading
전일 마감가:
$2.72
열려 있는:
$2.73
하루 거래량:
321.16K
Relative Volume:
0.43
시가총액:
$78.52M
수익:
-
순이익/손실:
$-75.52M
주가수익비율:
-1.0385
EPS:
-2.6
순현금흐름:
$-56.92M
1주 성능:
+19.47%
1개월 성능:
+31.71%
6개월 성능:
-86.69%
1년 성능:
-76.46%
1일 변동 폭
Value
$2.60
$2.74
1주일 범위
Value
$2.19
$3.00
52주 변동 폭
Value
$1.25
$32.41

Aerovate Therapeutics Inc Stock (AVTE) Company Profile

Name
명칭
Aerovate Therapeutics Inc
Name
전화
617-443-2400
Name
주소
930 WINTER STREET, WALTHAM
Name
직원
51
Name
트위터
Name
다음 수익 날짜
2024-08-12
Name
최신 SEC 제출 서류
Name
AVTE's Discussions on Twitter

Aerovate Therapeutics Inc Stock (AVTE) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-03-01 개시 Guggenheim Buy
2022-12-06 업그레이드 BTIG Research Neutral → Buy
2022-09-19 재개 Wedbush Outperform
2022-08-16 다운그레이드 BTIG Research Buy → Neutral
2022-02-11 개시 BTIG Research Buy
2021-07-26 개시 Cowen Outperform
2021-07-26 개시 Evercore ISI Outperform
2021-07-26 개시 Jefferies Buy
2021-07-26 개시 Wedbush Outperform
모두보기

Aerovate Therapeutics Inc 주식(AVTE)의 최신 뉴스

pulisher
12:45 PM

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATSG, STAF, AVTE on Behalf of Shareholders - Marketscreener.com

12:45 PM
pulisher
Nov 04, 2024

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Air Transport Services Group, Inc. (Nasdaq– ATSG), Micropac Industries, Inc. (OTC – MPAD), Aerovate Therapeutics, Inc. (Nasdaq – AVTE), Outbrain Inc. (Nasd - ForexTV.com

Nov 04, 2024
pulisher
Nov 04, 2024

AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc.AVTE - Marketscreener.com

Nov 04, 2024
pulisher
Nov 04, 2024

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Nov 04, 2024
pulisher
Nov 03, 2024

INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc.AVTE - PR Newswire

Nov 03, 2024
pulisher
Nov 02, 2024

Aerovate Therapeutics Enters into Merger Agreement with Jade Biosciences - Defense World

Nov 02, 2024
pulisher
Nov 01, 2024

How Fairmount’s Paragon incubator steered two more companies to NASDAQ - BioCentury

Nov 01, 2024
pulisher
Nov 01, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE and PFIE on Behalf of Shareholders - Marketscreener.com

Nov 01, 2024
pulisher
Nov 01, 2024

Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm - The Malaysian Reserve

Nov 01, 2024
pulisher
Nov 01, 2024

Finansavisen - Finansavisen

Nov 01, 2024
pulisher
Oct 31, 2024

SEC Form 425 filed by Aerovate Therapeutics Inc. - Quantisnow

Oct 31, 2024
pulisher
Oct 31, 2024

Aerovate (AVTE) Shares Rally As Market Responds To A Merger Agreement - Stocks Telegraph

Oct 31, 2024
pulisher
Oct 31, 2024

Jade, another biotech spinout of Paragon, to merge with Aerovate - BioPharma Dive

Oct 31, 2024
pulisher
Oct 31, 2024

Jade Biosciences and Aerovate announce merger deal - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders - Business Wire

Oct 31, 2024
pulisher
Oct 31, 2024

Aerovate to Merge With Jade Biosciences, Pursue Kidney Treatment - MarketWatch

Oct 31, 2024
pulisher
Oct 31, 2024

Shareholder Alert: Ademi LLP Investigates Whether Aerovate Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire

Oct 31, 2024
pulisher
Oct 31, 2024

Aerovate climbs on all-stock merger deal with Jade - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Aerovate stock rises on all-stock merger deal (AVTE:NASDAQ) - Seeking Alpha

Oct 31, 2024
pulisher
Oct 31, 2024

Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement - GlobeNewswire

Oct 31, 2024
pulisher
Oct 28, 2024

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Down 21.4% in October - MarketBeat

Oct 28, 2024
pulisher
Oct 17, 2024

Aerovate Therapeutics regains Nasdaq compliance - Investing.com India

Oct 17, 2024
pulisher
Oct 17, 2024

Aerovate Therapeutics regains Nasdaq compliance By Investing.com - Investing.com Canada

Oct 17, 2024
pulisher
Oct 17, 2024

Hypertension Clinical Trials 2024: FDA Approvals, Medication, Therapies, MOA, ROA, Companies by DelveInsight | Quantum Genomics, CinCor Pharma, Mineralys Therapeutics, Alnylam Therapeutics, Novartis - The Globe and Mail

Oct 17, 2024
pulisher
Oct 17, 2024

Cubist Systematic Strategies LLC Makes New Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Oct 17, 2024
pulisher
Oct 17, 2024

Cubist Systematic Strategies LLC Grows Holdings in Omega Therapeutics, Inc. (NASDAQ:OMGA) - Defense World

Oct 17, 2024
pulisher
Oct 14, 2024

Analyzing Aerovate Therapeutics Inc (AVTE) After Recent Trading Activity - Knox Daily

Oct 14, 2024
pulisher
Oct 13, 2024

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Update - MarketBeat

Oct 13, 2024
pulisher
Oct 10, 2024

Aerovate Therapeutics announces board member resignation - Investing.com India

Oct 10, 2024
pulisher
Oct 10, 2024

Aerovate Therapeutics announces board member resignation By Investing.com - Investing.com UK

Oct 10, 2024
pulisher
Oct 03, 2024

XTX Topco Ltd Invests $35,000 in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Oct 03, 2024
pulisher
Sep 28, 2024

Short Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Decreases By 15.7% - MarketBeat

Sep 28, 2024
pulisher
Sep 28, 2024

Bank of New York Mellon Corp Increases Stake in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Sep 28, 2024
pulisher
Sep 26, 2024

Deerfield Management Company L.P. Series C Takes Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Sep 26, 2024
pulisher
Sep 26, 2024

Deerfield Management Company L.P. Series C Acquires New Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat

Sep 26, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Makes New $332,000 Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

Market Highlights: Alector Inc (ALEC) Ends on a Low Note at 5.45 - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

AlgoTx completes pivotal phase 2 trial for ground-breaking CIPN treatment - PharmaTimes

Sep 24, 2024
pulisher
Sep 23, 2024

Why AeroVironment Shares Are Flying Higher Today - sharewise

Sep 23, 2024
pulisher
Sep 23, 2024

Alector (NASDAQ:ALEC) Shares Down 5.6% - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Defense Stock Soars on ‘Rare Move’ From the U.S. Army - Barron's

Sep 23, 2024
pulisher
Sep 23, 2024

AeroVironment (NASDAQ:AVAV) Shares Gap Up to $182.76 - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

AeroVironment Stock Is Rising Monday: What's Driving The Action? - Benzinga

Sep 23, 2024
pulisher
Sep 23, 2024

Altitude Group’s AGM: Mixed Shareholder Decisions - TipRanks

Sep 23, 2024
pulisher
Sep 23, 2024

AeroVironment Inc. (AVAV): Why Are Short Sellers Betting Against This Defense Tech Leader? - Insider Monkey

Sep 23, 2024
pulisher
Sep 23, 2024

Recent Insider Activity Suggests Potential Gains for Aerovate Therapeutics Inc (AVTE) - Knox Daily

Sep 23, 2024
pulisher
Sep 21, 2024

Alector (NASDAQ:ALEC) Stock Price Up 9% - Defense World

Sep 21, 2024
pulisher
Sep 19, 2024

Quest Partners LLC Increases Stock Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Alector, Inc. (NASDAQ:ALEC) Short Interest Down 5.7% in August - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

Allurion Technologies Inc. (NYSE:ALUR) Short Interest Up 8.6% in August - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Alignment healthcare CEO sells shares worth over $1m - Investing.com

Sep 18, 2024

Aerovate Therapeutics Inc (AVTE) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):